International Conference on

Epidemiology and Public Health

Theme: Emerging Technologies, Applications and Health Transitions in Epidemiology and Public Health

Event Date & Time

Event Location

Prague, Czech Republic

18 years of lifescience communication


Performers / Professionals From Around The Globe

Conference Speaker

Mariana Camara M B Furtado

Federal University of Rio Grande do Norte, Brazil

Conference Speaker

Vladimir Prikazsky

National Institute of Public Health ,Prague, Czech republic
Czech Republic

Conference Speaker

Professor Dr Ibrahim El Bayoumy

Professor of public health and community medicine-Tanta faculty of medicine

Conference Speaker

Dr. Samir Zakari

SVP, Distilled Spirits Council, USA

Conference Speaker

Vladimir Bencko

First Faculty if Medicine, Charles University, Prague, CZ
Czech Republic

Conference Speaker

Ali Al- Hemoud

Environment and Life Sciences Research Center, Kuwait

Tracks & Key Topics

Epidemiology 2019

About Conference

The EuroSciCon is welcoming for Conference on Epidemiology 2019 on February 27-28, 2019, Prague, Czech Republic. The topic of the current year's gathering Emerging Technologies, Applications and Health transitions in Epidemiology and Public Health which will give a worldwide stage to talk of present and future  of Epidemiology. The extension of two committed streams for the EuroSciCon Conference on Epidemiology 2019 gathering was a hit we could get learning from two specific gathering one that surpassed desires in the deliberate and collecting end and one that surpassed desires in the business and key end. The 2019 foundation of this gathering will empower us to continue plunging further into both the examination of Epidemiology change and the business necessities for associations.

The Organizing Committee is satisfied to welcome you to attend the EuroSciCon Conference   on Epidemiology, one of its astonishing Pharmaceutical gatherings to be held in the midst February 27-28, 2019, Prague, Czech Republic EuroSciCon Conference on Epidemiology joins scientists, authorities and CROs from around the world. With the support of Epidemiology by the USFDA-Inflectra, the Epidemiology promote is had to experience an exponential improvement over the coming couple of years. Various Biologics things are affecting their passage in the Pharma to publicize and experiencing a striking climb in their utilization over the standard remedies.

At Epidemiology 2019 meet your planned intrigue bunches from around the world focused on getting some answers concerning Epidemiology and Public Health. This gathering would be your single most obvious opportunity to accomplish the greatest accumulation of individuals from the Epidemiology and Public Health gathering.

Why to Attend?

Join your companions the world over focused on getting some answers concerning Epidemiology and Public Health related advances, which is your single most obvious opportunity to accomplish the greatest gathering of individuals from the Epidemiology and Public Health society, coordinate shows, scatter information, meet with recurring pattern and potential specialists, make a sprinkle with new research works, and get name affirmation at this Two-day event. Broadly acclaimed speakers, the most recent research, moves, and the most momentum refreshes in Epidemiology and Public Health are indications of this gathering. Provision of information on new technologies implemented in the field of Epidemiology and Public Health and a sound knowledge on the Clinical Trail Development Provides interaction with the world's well known CEO's and Directors of the Pharmaceutical companies.

Benefits to attend Epidemiology 2019:

a) Keynote introduction alongside connections to excite established researchers.

b) Workshop and symposiums to achieve the biggest array of members from the Pharma/Biotech people group.

c) A wide track of exhibitors to grandstand the new and rising advancements

d) Platform to worldwide speculation group to interface with partners in Pharma/Biotech area

e) Links to the political promoting assets keeping in mind the end goal to extend your business and research organize

f) Triumph of Awards, Certificates perceives your sense of duty regarding your calling to empower the incipient research.

Epidemiology 2019 Benefits:

• Open board exchanges: Providing an open gathering with specialists from the scholarly world and business to talk about on current difficulties in Epidemiology and Public Health, where all participants can collaborate with the board took after by a Q&A session.

• Speaker and notice introductions: Providing a stage to all academicians and industry experts to share their exploration contemplations and discoveries through a discourse or a publication introduction.

• Editorial executive gathering: Discussing on development and advancement of open access Bioanalysis, Immunology, Pathology and Biomedicine International Journals and enlisting board individuals and analysts who can bolster the diary.

• Round table gatherings: Providing a stage where industry experts meet scholastic specialists.

Business and Exhibitor Benefits:

Over 50+ organizations and international pavilions will be exhibiting at the EuroSciCon  Epidemiolog2019 Conference. Exhibitors will include equipment manufacturers and suppliers, systems providers, finance and investment firms, R&D companies, project developers, trade associations, and government agencies.

In addition to the products and services you will have access to valuable content, including Keynote Presentations, Product Demonstrations and Educational Sessions from today’s industry leaders.

The EuroSciCon  Epidemiolog2019 has everything you need, all under one roof, saving you both time and money.   It is the event you cannot afford to miss!

Target Audience:

• Executives, CEO's of Organizations

• Business Development Managers

• Boss Scientific Officers

• Research and development Researchers from Epidemiology and Public Health Industries

• Educators, Associate Professors, Assistant Professors

• PhD Scholars

• Patent Attorneys

• Protected innovation Attorneys

• Speculation Analysts

• Affiliation, Association presidents and experts

• Honorable laureates in Health Care and Medicine

• Bio instruments Professionals

Bio-informatics Professionals

• Programming improvement organizations

• Research Institutes and individuals

• Inventory network organizations

• Assembling Companies

• CRO (Contract Research Organization) and DATA administration Companies

• Preparing Institutes

• Business Entrepreneurs

About Venue:

Prague is the capital and largest city in the Czech Republic, the 14th largest city in the European Union and also the historical capital of Bohemia. Situated in the north-west of the country on the Vltava River, the city is home to about 1.3 million people, while its larger urban zone is estimated to have a population of 2.6 million. Prague is home to a number of famous cultural attractions, many of which survived the violence and destruction of 20th-century Europe. Main attractions include the PragueCastle, the Charles Bridge, Old Town Square with the Prague astronomical clock, the Jewish Quarter, Petrin hill and Vyšehrad. The city has a temperate climate, with warm summers and chilly winters


Session and Tracks

Epidemiology and Public Health

Public health is concerned with protecting the health of entire populations. These populations can be as small as a local neighborhood, or as big as an entire country or region of the world. Public Health is a part of sciences, skills and convictions that is focused on the preservation. In descriptive epidemiology, scientists do use of available data to identify health related problems. Epidemiology and Demography 

Epidemiology and Medicine

In modern clinical practice, doctors personally diagnose, treat, and prevent disease using clinical epidemiology. The doctor and patient relationship typically begins with an examination of the patient's medical history and medical record, a physical examination. Epidemiology and Preventive Medicine has broad expertise in applied clinical and public health research

Epidemiology and Surveillance

Epidemiologic surveillance is the continuous systematic collection, recording, study, analysis, and dissemination of data reflecting the current public health status of society. The scope of epidemiologic surveillance has derived from primary focus on infectious disease monitoring and intervention to a more scope that includes injuries, environmental exposures, and social factors that influence health status.

Epidemiology and Infectious Diseases

Emerging infectious diseases are induced by various microorganisms, such as bacteria, viruses, parasites or fungi; the diseases can be spread from one person to another. Infectious Disease Epidemiology helps us to understand the correlations of contaminating agents, their hosts, vectors and environment. This information helps in understanding of how disease patterns vary among populations and how that impacts development of advanced therapies and treatment interventions.

Epidemiology and Antibiotic Resistance

Antibiotics and similar drugs, together called antimicrobial agents, have been used for the last 70 years to treat patients who have infectious diseases. These drugs are helping to cure illness and death from infectious diseases. However, these drugs have been implemented so widely and for so long to kill infectious organisms..

Epidemiology and chronic diseases

The Chronic Disease Epidemiology Department (CDE) is to advance the health of the public by promoting a research-based approach to the prevention and management of chronic disease. Research in the chronic disease epidemiology cluster addresses the etiology, prevention, distribution, natural history, and treatment outcomes of chronic health disorders, including cancer (particularly breast, colon, lung, prostate, ovary and pancreas), cardiovascular disease, diabetes, gastrointestinal and pulmonary disease, and obesity

  • Epidemiology and prevalence chronic disease
  • Epidemiology and Incidence chronic disease

Epidemiology and Oral Health

Studies conducted in the field of oral health epidemiology provide information on normal biological processes and on diseases of the oral cavity, identify populations at risk of oral disease or in need of specific care, and compare regional, environmental, social, and access similarities and differences in dental care between populations. Oral epidemiology also tests preventive interventions for controlling disease and evaluates the effectiveness and quality of interventions and oral health programs.

Epidemiology and Genomic Research

Epidemiology beyond the basics, that can help geneticists to overcome these problems, specifically by providing the infrastructure to collect large phenotype samples from affected and unaffected individuals drawn from similar ethnic backgrounds. The recent revolution in genomics is already having a profound impact on the practice of epidemiology. Typically these disciplines  are derived from population-based, natural history studies of specific diseases, often established years ago prior to the evolution of the technology that underpins the genomics revolution.

Epidemiology and Sociology

The relationship between social class and health has been a major research field since the beginning of public health history. Many studies have identified the disparities in health among social classes and developed several theories, such as social selection theory and socio-biological translation theory.

Epidemiology and Public Health Nursing

Public health nursing focuses on person’s health that is affected by many factors, including genetic makeup, lifestyle and environment. They go into communities to try and help people to improve their health and prevent disease. 

  • Epidemiology and preventive care
  • Epidemiology and screening services
  • Epidemiology and health education

Epidemiology and Environmental Health

This is the branch of epidemiology which is dealing with the discovery of the environmental exposures that protect against injuries, illnesses, disabilities, and identification of public health and health care actions to prevent the risks associated with harmful exposures.


Epidemiology and cancer

The epidemiology of cancer is the study of the factors affecting cancer, as a way to infer possible trends and causes. The study of cancer epidemiology uses epidemiological methods to find the cause of cancer and to identify and develop improved treatments.

Epidemiology and tuberculosis

Study of the epidemiology of tuberculosis has been greatly assisted by the availability of a test for infection, the tuberculin test, that enables one to distinguish those who are infected but without disease from those who are uninfected. The principal risk for acquiring infection with Mycobacterium tuberculosis is breathing. Tuberculosis due to reactivation of latent bacilli is presumed to result from a failure in immune surveillance. 

Epidemiology and Molecular

Molecular epidemiology is a branch of epidemiology and medical science that focuses on the contribution of potential genetic and environmental risk factors, identified at the molecular level, to the etiology, distribution and prevention of disease within families and across populations. This field has emerged from the integration of molecular biology into traditional epidemiological research. .

Epidemiology and Injury

Injury epidemiology is the characterization of injury occurrence, the identification of risk factors and the strength of effect of those factors, as well as potentially protective factors related to the development and evaluation of injury prevention strategies and programs. Injuries can occur in every environment from homes to the workplace, recreational settings including sports settings, and to transportation settings between these environments.


Epidemiology and Obesity

Obesity has been observed throughout human history. Many early depictions of the human form in art and sculpture appear obese. However, it was not until the 20th century that obesity became common so much so that, in 1997, the World Health Organization (WHO) formally recognized obesity as a global epidemic. Obesity is defined as having a body mass index (BMI) greater than or equal to 30 kg/m2, and in June 2013 the American Medical Association classified it as a disease, with much controversy.


Epidemiology and Risk Factor

In epidemiology, a risk factor is a variable associated with an increased risk of disease or infection. When evidence is found the term determinant is used as a variable associated with either increased or decreased risk.



Epidemiology and Molecular pathology

Molecular pathological epidemiology (MPE, also molecular pathologic epidemiology) is a discipline combining epidemiology and pathology. It is defined as epidemiology of molecular pathology and heterogeneity of disease. Pathology and epidemiology share the same goal of elucidating etiology of disease, and MPE aims to achieve this goal at molecular, individual and population levels

Epidemiology and Nutrition

Nutritional epidemiology is a relatively new field of medical research that studies the relationship between nutrition and health. Diet and physical activity are difficult to measure accurately, which may partly explain why nutrition has received less attention than other risk factors for disease in epidemiology.


Media Partners/Collaborator

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker


A huge thanks to all our amazing partners. We couldn’t have a conference without you!